glp 1 for dementia He's Betting on a GLP-1 To Help Prevent Alzheimer's. Scientists Aren't Sure It Works Yet GLP-1R agonists protect against Alzheimer's

The FDA perspective on compounded semaglutide Understanding the regulatory landscape helps you make informed decisions about using compounded sublingual drops

These data are consistent with the T allele decreasing risk for T2D, as well as decreasing glucose and HbA1c levels, but slightly increasing the risk of smoking initiation (Supplementary Table 16)

Inhibitory effects of epigallocatechin-3-gallate on microsomal cyclooxygenase-1 activity in platelets

On August 27, 2025, the FDA approved the first generic version of liraglutide (Saxenda) for weight loss in adults and adolescents with obesity and adults with overweight and at least one weight-related comorbid condition

(12(4)) doi:10.3390/children12040442

We chose 2018 as the starting year because the most recent approved GLP-1 RA (semaglutide) except for tirzepatide was marketed in 2017, and the ending date was set as the most recent quarter when data were available